Leone Asset Management Acquires Sinol USA

Belleair Bluffs, Florida, January 5, 2017 (Newswire.com) - ​​Today, Leone Asset Management (PINK SHEETS: LEON) announces they have acquired Sinol USA, Inc., an innovative healthcare company based in Newtown, Connecticut.

James Price, CEO of Leone Asset stated, “The Sinol products and its management team are top-notch and the acquisition of Sinol USA fits perfectly into our growth and expansion plans for our Health and Wellness vertical.   Currently, Sinol is being distributed throughout the USA and several other countries through pharmacy chains and independent locations.  We intend on adding a much larger distribution network and aggressively marketing and advertising the Sinol products both domestically and internationally, and will also utilize the current Sinol distribution channels to integrate further distribution of Cholesterade® and other product lines that we own. 

President of Sinol Paul Carpenter, will continue his role as President and will work directly with Leone Asset subsidiary Go Epic Health on all aspects of marketing, distribution and expansion plans for Sinol and all other Go Epic products.”

About Leone Asset Management

Leone Asset Management, Inc., is a multi-national, multi-industry conglomerate with subsidiary companies that operate in Health and Wellness in the U.S., Technology Development in India and Infrastructure development, agriculture management, and mineral exploration and export in Africa. For additional information, visit: www.leoneasset.com.

About Sinol USA

Sinol USA, Inc., is a healthcare company dedicated to exceeding the needs of today's consumers by creating healthcare products using 100% all natural ingredients.  With so many prescription medications adding additional health risks, it is imperative that people have a natural choice when it comes to their own health care. By understanding the need for healthier medicines, Sinol has raised the bar, by formulating a unique combination of clean, old-fashioned ingredients with new innovative technology. We have created the first capsaicin based, FDA approved, over the counter nasal spray for fast relief from allergy and sinus congestion and headaches of all degrees and types. Our dedication to providing a healthier medical alternative has been widely recognized and applauded by doctors and medical communities, and it is our mission to heal our customers suffering with clean all natural nasal spray products. We believe in giving our customers fast relief and peace of mind in knowing that they have made the right choice in using our all-natural products.  For further information, please visit www.sinolusa.com

About Go Epic Health

Go Epic Health, a Leone Asset Management subsidiary, is a nutritional product holding company which owns the intellectual property and worldwide manufacturing and distribution rights to Cholesterade®, a natural cholesterol reducing product created by the late Dr. Robert Cade, creator of Gatorade®. Go Epic's wholly owned subsidiary, American Retail Alliance, markets and distributes Cholesterade® as well as other new and innovative consumer goods through the nation's largest retail pharmacy chain stores, drug and health food stores, multi-level organizations, and product specific catalogs. Wholly owned subsidiary Eagle Labs is a product and contract manufacturing company specializing in manufacturing food, cosmetics, dietary supplements, liquid bottling and product formulation. For further information, please visit www.goepichealth.com and www.gocholesterade.com.

Forward-Looking Statements Disclosure:

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," " plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matter that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward -looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.

Contact:

James Price
​CEO
Leone Asset Management
(727) 581-1500
[email protected]

Source: Leone Asset Management